Demographics, clinical characteristics, treatment (tx) patterns and clinical outcomes for patients ( pts) with limited-stage SCLC (LS-SCLC)

被引：0
|
作者：
Chiang, A. C. [1 ]
Salomonsen, R. J-B. [2 ]
Wang, A. [2 ]
Holland, R. [3 ]
Cai, L. [2 ]
Xiao, Y. [2 ]
Sadow, S. [2 ]
Davey, K. [3 ]
Iyengar, P. [4 ]
机构：
[1] Yale Univ, Sch Med, Thorac Oncol, New Haven, CT USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] AstraZeneca, Cambridge, England
[4] UT Southwestern Med Ctr Dallas, Dallas, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
168P
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [1] Real-world Demographics, Clinical Characteristics, Treatment Patterns and Clinical Outcomes for US Patients with Limited-Stage SCLC (LS-SCLC)
    Chiang, Anne C.
    Salomonsen, Rachel
    Wang, Alice
    Holland, Rachel
    Cai, Ling
    Xiao, Yang
    Sadow, Sam
    Davey, Kieran
    Iyengar, Puneeth
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E40 - E41
  • [2] ADRIATIC: Durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC).
    Spigel, David R.
    Cheng, Ying
    Cho, Byoung Chul
    Laktionov, Konstantin K.
    Fang, Jian
    Chen, Yuanbin
    Zenke, Yoshitaka
    Lee, Ki Hyeong
    Wang, Qiming
    Navarro, Alejandro
    Bernabe Caro, Reyes
    Buchmeier, Eva Lotte
    Chang, John W. C.
    Okamoto, Isamu
    Goksu, Sema Sezgin
    Badzio, Andrzej
    Gill, Bethany
    Gowda, Hema
    Jiang, Haiyi
    Senan, Suresh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL)
  • [3] Cisplatin versus carboplatin for the treatment of limited-stage small cell lung cancer (LS-SCLC).
    Azar, Ibrahim
    Austin, Adam
    Kim, Seongho
    Jang, Hyejeong
    Surapaneni, Malini
    Kurtz, Daniel
    Yazdanpanah, Omid
    Chopra, Amit
    Mehdi, Syed
    Mamdani, Hirva
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Patterns of practice in limited-stage small cell lung cancer (LS-SCLC) among radiation oncologists
    Movsas, Benjamin
    Sun, Alexander
    Komaki, Ritsuko
    Bonner, James
    Choy, Hak
    Gaspar, Laurie
    Sandler, Howard M.
    Kong, Feng-Ming
    CHEST, 2007, 132 (04) : 589S - 589S
  • [5] Adaptive radiation therapy (ART) for patients with limited-stage small cell lung cancer (LS-SCLC): A dosimetric evaluation
    Sager, Omer
    Dincoglan, Ferrat
    Demiral, Selcuk
    Uysal, Bora
    Gamsiz, Hakan
    Ozcan, Fatih
    Colak, Onurhan
    Elcim, Yelda
    Gundem, Esin
    Dirican, Bahar
    Beyzadeoglu, Murat
    INDIAN JOURNAL OF CANCER, 2023, 60 (01) : 140 - 147
  • [6] Improving outcomes for limited stage small cell lung cancer (LS-SCLC) patients in Scotland with concomitant chemoradiation
    Law, A
    Kerr, G
    Mackean, M
    Erridge, S
    Little, F
    Ironside, J
    Price, A
    LUNG CANCER, 2005, 49 : S324 - S324
  • [7] Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial
    Senan, S.
    Spigel, D. R.
    Cho, B. C.
    Laktionov, K.
    Zenke, Y.
    Lee, K. H.
    Wang, Q.
    Mendivil, A. F. Navarro
    Buchmeier, E. L.
    Goksu, S. Sezgin
    Badzio, A.
    Shi, A.
    Daniel, D. B.
    Zemanova, M.
    Iyengar, P.
    Paz-Ares, L. G.
    Szadkowski, L.
    Chugh, P.
    Lai, W. C. V.
    Cheng, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : 1267 - 1268
  • [8] Phase I study with pemetrexed, cisplatin and concurrent radiotherapy in limited-stage small cell lung cancer (LS-SCLC)
    Surmont, V.
    Nackaerts, K.
    Senan, S.
    Kraaij, C. J.
    Chouaki, N.
    van Klaveren, R. J.
    Vansteenkiste, J.
    Smit, E. F.
    EJC SUPPLEMENTS, 2009, 7 (02): : 541 - 541
  • [9] CPT-11-CARBOPLATIN WITH EARLY CONCURRENT RADIOTHERAPY (CT/RT) IN LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) PATIENTS (PTS). A PHASE II STUDY
    Domine, M.
    Leon, A.
    Casado, V.
    Rubio, G.
    Martin, I.
    Arlanzon, C.
    Ortega, C.
    Ramirez, N.
    Fuentes, R.
    Lobo, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 117 - 117
  • [10] Is Prophylactic Cranial Irradiation (PCI) With Hippocampal Avoidance (HA) Justified in Limited-Stage Small Cell Lung Cancer (LS-SCLC)?
    Mishra, M. V.
    Louie, A. V.
    Gondi, V.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S594 - S595
12345